Follow
Suhaila O. Alhaj Suliman
Suhaila O. Alhaj Suliman
PhD in Pharmaceutical Sciences
Verified email at uiowa.edu
Title
Cited by
Cited by
Year
Engineering nanosystems to overcome barriers to cancer diagnosis and treatment
SO Alhaj-Suliman, EI Wafa, AK Salem
Advanced drug delivery reviews 189, 114482, 2022
282022
New 1, 2, 3-triazole linked ciprofloxacin-chalcones induce DNA damage by inhibiting human topoisomerase I& II and tubulin polymerization
HHH Mohammed, AA Abd El-Hafeez, K Ebeid, AI Mekkawy, ...
Journal of enzyme inhibition and medicinal chemistry 37 (1), 1346-1363, 2022
212022
Cationic nanoparticles enhance T-cell tumor infiltration and antitumor immune response to a melanoma vaccine
R Smith, EI Wafa, SM Geary, K Ebeid, SO Alhaj-Suliman, AK Salem
Science Advances, 2022
172022
Paclitaxel anticancer activity is enhanced by the MEK 1/2 inhibitor PD98059 in vitro and by PD98059-loaded nanoparticles in BRAFV600E melanoma-bearing mice
AI Mekkaw, YW Naguib, SO Alhaj-Suliman, EI Wafa, K Ebeid, T Acri, ...
International Journal of Pharmaceutics, 2021
122021
Polymeric particles as cancer vaccine vectors
SO Alhaj-Suliman, EI Wafa, SM Geary, AK Salem
American Pharmaceutical Review 22 (3), 32-39, 2019
5*2019
Ciprofloxacin Derivative‐Loaded Nanoparticles Synergize with Paclitaxel Against Type II Human Endometrial Cancer
YW Naguib, SO Alhaj‐Suliman, EI Wafa, S Saha, K Ebeid, ...
Small, 2302931, 2023
32023
Model-based meta-analysis to compare primary efficacy-endpoint, efficacy-time course, safety, and tolerability of opioids used in the management of osteoarthritic pain in humans
SO Alhaj-Suliman, G Milavetz, AK Salem
Current drug metabolism 21 (5), 390-399, 2020
22020
A ciprofloxacin derivative with four mechanisms of action overcomes paclitaxel resistance in p53-mutant and MDR1 gene-expressing type II human endometrial cancer
SO Alhaj-Suliman, YW Naguib, EI Wafa, S Saha, K Ebeid, X Meng, ...
Biomaterials 296, 122093, 2023
12023
Compositions and methods for treating cancer
AK Salem, K Ebeid, YWN Ibrahim, S Saha, EI Wafa, S Alhaj-Suliman
US Patent App. 17/890,757, 2024
2024
Injectable long-acting ivacaftor-loaded poly (lactide-co-glycolide) microparticle formulations for the treatment of cystic fibrosis: In vitro characterization and in vivo …
DS Nakhla, AI Mekkawy, YW Naguib, AD Silva, D Gao, JA Kim, ...
International journal of pharmaceutics 650, 123693, 2024
2024
Compositions and methods for treating cancer
KE Aliasger K. Salem, Youssef W. Naguib, Suhaila O. Alhaj-Suliman, Emad I ...
US Patent App. 63/234,492, 2021
2021
The system can't perform the operation now. Try again later.
Articles 1–11